Accumulating evidence has shown that ZEB2 has a major role in the EMT process, including growth, differentiation, resistance to therapy and apoptosis, metastatic potential, and tumor recurrence (Fardi et al., 2019). This evidence concerns the gene ZEB2 and neoplasm.